Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.

The facility will be built in Silicon Valley and bring Lilly’s lab expertise closer to the center of artificial intelligence innovation, Nvidia said on Monday. The company described the project as a joint investment, without elaborating on the financial terms.

The hope is to supercharge a time-consuming process that currently relies heavily on human researchers conducting physical experiments.

The investment is the latest example of Nvidia using ...